Medford, MA, United States of America

Engin Hassamanci

This inventor holds 1 USPTO granted patent. Top assignee: Bayer Healthcare LLC. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Engin Hassamanci. Retrieved from https://idiyas.com/inventor/engin-hassamanci-58yuggi9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Engin Hassamanci: Innovator in Fluid Injection Technology.

Introduction

Engin Hassamanci is a notable inventor based in Medford, MA (US). He has made significant contributions to the field of fluid injection technology. With a focus on innovation, he has developed a patent that showcases his expertise and creativity.

Latest Patents

Engin Hassamanci holds a patent for a fluid injector. This invention demonstrates his ability to address complex challenges in the healthcare industry. His work is recognized for its potential impact on medical applications.

Career Highlights

Engin is currently employed at Bayer Healthcare LLC, where he continues to advance his research and development efforts. His role at Bayer allows him to collaborate with other talented professionals in the field.

Collaborations

Some of his coworkers include Linda Van Roosmalen and Gerald W Callan. Their collective expertise contributes to the innovative environment at Bayer Healthcare LLC.

Conclusion

Engin Hassamanci is a dedicated inventor whose work in fluid injection technology is paving the way for advancements in healthcare. His contributions are valuable to the industry and reflect his commitment to innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…